Literature DB >> 9359420

Thiocyanate and chloride as competing substrates for myeloperoxidase.

C J van Dalen1, M W Whitehouse, C C Winterbourn, A J Kettle.   

Abstract

The neutrophil enzyme myeloperoxidase uses H2O2 to oxidize chloride, bromide, iodide and thiocyanate to their respective hypohalous acids. Chloride is considered to be the physiological substrate. However, a detailed kinetic study of its substrate preference has not been undertaken. Our aim was to establish whether myeloperoxidase oxidizes thiocyanate in the presence of chloride at physiological concentrations of these substrates. We determined this by measuring the rate of H2O2 loss in reactions catalysed by the enzyme at various concentrations of each substrate. The relative specificity constants for chloride, bromide and thiocyanate were 1:60:730 respectively, indicating that thiocyanate is by far the most favoured substrate for myeloperoxidase. In the presence of 100 mM chloride, myeloperoxidase catalysed the production of hypothiocyanite at concentrations of thiocyanate as low as 25 microM. With 100 microM thiocyanate, about 50% of the H2O2 present was converted into hypothiocyanite, and the rate of hypohalous acid production equalled the sum of the individual rates obtained when each of these anions was present alone. The rate of H2O2 loss catalysed by myeloperoxidase in the presence of 100 mM chloride doubled when 100 microM thiocyanate was added, and was maximal with 1mM thiocyanate. This indicates that at plasma concentrations of thiocyanate and chloride, myeloperoxidase is far from saturated. We conclude that thiocyanate is a major physiological substrate of myeloperoxidase, regardless of where the enzyme acts. As a consequence, more consideration should be given to the oxidation products of thiocyanate and to the role they play in host defence and inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359420      PMCID: PMC1218820          DOI: 10.1042/bj3270487

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Concentration of thiocyanate and ionizable iodine in saliva of smokers and nonsmokers.

Authors:  J Tenovuo; K K Mäkinen
Journal:  J Dent Res       Date:  1976 Jul-Aug       Impact factor: 6.116

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Accumulation of hypothiocyanite ion during peroxidase-catalyzed oxidation of thiocyanate ion.

Authors:  T M Aune; E L Thomas
Journal:  Eur J Biochem       Date:  1977-10-17

4.  Human eosinophil peroxidase: a novel isolation procedure, spectral properties and chlorinating activity.

Authors:  R Wever; H Plat; M N Hamers
Journal:  FEBS Lett       Date:  1981-01-26       Impact factor: 4.124

5.  Properties of prolyl 4-hydroxylase containing firmly-bound iron.

Authors:  J J Nietfeld; A Kemp
Journal:  Biochim Biophys Acta       Date:  1980-06-13

6.  Lactoperoxidase-catalyzed oxidation of thiocyanate: equilibria between oxidized forms of thiocyanate.

Authors:  E L Thomas
Journal:  Biochemistry       Date:  1981-05-26       Impact factor: 3.162

7.  Direct potentiometric determination of chloride ion in whole blood.

Authors:  S Oka; Y Sibazaki; S Tahara
Journal:  Anal Chem       Date:  1981-04       Impact factor: 6.986

8.  Isolation and properties of human neutrophil myeloperoxidase.

Authors:  N R Matheson; P S Wong; J Travis
Journal:  Biochemistry       Date:  1981-01-20       Impact factor: 3.162

9.  The rapid determination of total bromine and iodine in biological fluids by neutron activation.

Authors:  J Holzbecher; D E Ryan
Journal:  Clin Biochem       Date:  1980-12       Impact factor: 3.281

10.  Myeloperoxidase of the leukocyte of normal blood. I. Reaction of myeloperoxidase with hydrogen peroxide.

Authors:  T Odajima; I Yamazaki
Journal:  Biochim Biophys Acta       Date:  1970-04-22
View more
  97 in total

1.  Spectrophotometric determination of leukocytes in blood.

Authors:  Huriye Kuzu-Karsilayan; Eda Eryilmaz; Gaye Yillar; Günnur Deniz; Gülderen Yanikkaya-Demirel
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  rhEPO (recombinant human eosinophil peroxidase): expression in Pichia pastoris and biochemical characterization.

Authors:  Chiara Ciaccio; Alessandra Gambacurta; Giampiero De Sanctis; Domenico Spagnolo; Christina Sakarikou; Giovanni Petrella; Massimo Coletta
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

3.  The lactoperoxidase system links anion transport to host defense in cystic fibrosis.

Authors:  Gregory E Conner; Corinne Wijkstrom-Frei; Scott H Randell; Vania E Fernandez; Matthias Salathe
Journal:  FEBS Lett       Date:  2006-12-19       Impact factor: 4.124

4.  2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.

Authors:  Anna-Karin Tidén; Tove Sjögren; Mats Svensson; Alexandra Bernlind; Revathy Senthilmohan; Francoise Auchère; Henrietta Norman; Per-Olof Markgren; Susanne Gustavsson; Staffan Schmidt; Stefan Lundquist; Louisa V Forbes; Nicholas J Magon; Louise N Paton; Guy N L Jameson; Håkan Eriksson; Anthony J Kettle
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

5.  Antiinflammatory and Antimicrobial Effects of Thiocyanate in a Cystic Fibrosis Mouse Model.

Authors:  Joshua D Chandler; Elysia Min; Jie Huang; Cameron S McElroy; Nina Dickerhof; Tessa Mocatta; Ashley A Fletcher; Christopher M Evans; Liping Liang; Manisha Patel; Anthony J Kettle; David P Nichols; Brian J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

6.  Nebulized thiocyanate improves lung infection outcomes in mice.

Authors:  J D Chandler; E Min; J Huang; D P Nichols; B J Day
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  Small molecular, macromolecular, and cellular chloramines react with thiocyanate to give the human defense factor hypothiocyanite.

Authors:  Bheki A Xulu; Michael T Ashby
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

Review 8.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

9.  Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition.

Authors:  Semira Galijasevic; Ghassan M Saed; Michael P Diamond; Husam M Abu-Soud
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.

Authors:  Martin D Rees; John M Whitelock; Ernst Malle; Christine Y Chuang; Renato V Iozzo; Anastasia Nilasaroya; Michael J Davies
Journal:  Matrix Biol       Date:  2009-09-27       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.